20 Million COVID Vaccine Doses Ready for Year End Shipping

According to an article published in WBUR, the third and final clinical trial for Moderna’s coronavirus vaccine is still underway, but the company is already setting an aggressive schedule to manufacture and ship the vaccine immediately if the Food and Drug Administration approves it.

“By the end of this year, we expect to have approximately 20 million doses ready to ship in the U.S.,” Moderna chief medical officer Dr. Tal Zaks said at an investor briefing on Thursday. “From a distribution...

https://mfame.guru/20-million-covid-vaccine-doses-ready-for-year-end-shipping/

Real Time Reviewing of the Oxford COVID Vaccine Begins

According to a Reuters report, AstraZeneca Plc said on Sunday that Britain’s health regulator had started an accelerated review of its potential coronavirus vaccine.

Reviewing Real-Time Clinical Data

“We confirm the MHRA’s (Medicines and Healthcare Products Regulatory Agency) rolling review of our potential COVID-19 vaccine,” an AstraZeneca spokesman said.

In rolling reviews, regulators are able to see clinical data in real time and have a dialogue with drug makers on manufacturing processes and...

https://mfame.guru/real-time-reviewing-of-the-oxford-covid-vaccine-begins/

DOD planning ‘every logistical detail’ of COVID vaccine distribution

U.S. military personnel unloading equipment from back of a

U.S. military leaders and logistics specialists are working on multiple fronts to ensure rapid distribution of COVID-19 vaccines. Efforts include reducing red tape for imports and exports of clinical trial materials and coordinating logistics plans with public health jurisdictions across the country.

The Department of Defense is essentially serving as a lead logistics provider, applying its vast logistical capabilities to coordinate with private sector manufacturing and freight transportation...

https://www.freightwaves.com/news/dod-planning-every-logistical-detail-of-covid-vaccine-distribution

COVID vaccine fallout: General air cargo, wait your turn

Big pallet of shrink-wrapped cargo being rolled under the wing of a cargo plane on a sunny day.

Shippers of general commodities such as auto parts, wine, apparel and telecommunications equipment should be prepared for air transportation delays in the coming months, because any new releases of COVID-19 vaccines will take priority, logistics experts say.

Cargo carriers, including airlines operating passenger aircraft as mini-freighters, are likely to bump general cargo from flights to make room for emergency shipments of lifesaving vaccines, which also will command the highest rates because...

https://s29755.pcdn.co/news/covid-vaccine-fallout-general-cargo-wait-your-turn

Maersk Partners With COVID Vaccine Developers for Effective Distribution

Maersk has announced that they have entered a partnership with manufacturer Covaxx for the distribution of its COVID-19 vaccine — which is currently in phase 1 clinical trials — once it is approved by regulatory authorities, reports Supply Chain Dive.

Vaccine Supply Chain Management 

The agreement between the two companies lays out a plan for the end-to-end supply chain management of the vaccine, from packing to shipping to warehousing.

 The announcement said the agreement is for distribution in “e...

https://mfame.guru/maersk-partners-with-covid-vaccine-developers-for-effective-distribution/

First COVID Vaccine Approval To Reduce Research of Other Vaccines

According to a Science Magazine report, the first vaccine to cross the finish line might be only marginally effective, yet it could become the enemy of the good—or even the great—candidates in the wings by disrupting ongoing studies.

What’s the issue?

In all likelihood, the U.S. Food and Drug Administration (FDA) or other regulators will issue the first COVID-19 vaccine approval or emergency use authorization (EUA) for one vaccine while many other candidates have clinical trials still underway or...

https://mfame.guru/first-covid-vaccine-approval-to-reduce-research-of-other-vaccines/

MI5 Chief Underline Threats To COVID Vaccine Research

In a major development, Reuters has reported that British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage research data in the race for the global prize of a jab that could provide immunity, the head of MI5 said on Wednesday.

Britain’s MI5 spy chief on COVID-19, China, Russia and threats

More than 150 potential vaccines are being developed and tested globally to stop the COVID-19 pandemic, with 42 in human trials, according to the...

https://mfame.guru/mi5-chief-underline-threats-to-covid-vaccine-research/

COVID Vaccine Manufacturers Gets Lawsuit Protection

According to a News07Trends article, the U.S. authorities paid out $4 billion over greater than 30 years protecting accidents regarding a bunch of vaccines—from flu to polio—however payouts for potential accidents from Covid-19 vaccines shall be lined by a far less-generous program.

The Counter Measure  Covid Vaccine Proof

Covid-19 vaccine accidents shall be lined underneath a program often called the “countermeasures harm” compensation fund, which was arrange in 2010 to cowl hurt ensuing from...

https://mfame.guru/covid-vaccine-manufacturers-gets-lawsuit-protection/

Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.
icon